Constellation Brands' New Chief Wants to Win the Pool Cooler
Marvell Secures Spot In S&P 500 Index Amid AI Chip Boom
Argenx Eyes Larger Patient Pool Following Expanded FDA Nod For Lead Drug For Neuromuscular Disease
Pool Corp Q1 Earnings: EPS And Sales Beat Estimates, Stock Gains On Raised Guidance